Nie Wenlong, Liu Yun, Lan Jinshuai, Li Ting, He Yitian, Li Zhe, Zhang Tong, Ding Yue
School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201210, People's Republic of China.
Int J Nanomedicine. 2024 Apr 8;19:3405-3421. doi: 10.2147/IJN.S449268. eCollection 2024.
Natural nanoparticles have been found to exist in traditional Chinese medicine (TCM) decoctions. However, whether natural nanoparticles can influence the oral bioavailability of active compounds has not been elucidated. Using Xie-Bai-San decoction (XBSD) as an example, the purpose of this study was to isolate, characterize and elucidate the mechanism of the nanoparticles (N-XBSD) in XBSD, and further to explore whether the bioavailability of the main active compounds could be enhanced by N-XBSD.
N-XBSD were isolated from XBSD, and investigated its characterization and study of its formation mechanism, and evaluation of its ability to enhance bioavailability of active compounds.
The N-XBSD was successfully isolated with the average particle size of 104.53 nm, PDI of 0.27 and zeta potential of -5.14 mV. Meanwhile, all the eight active compounds were most presented in N-XBSD. Kukoamine B could self-assemble with mulberroside A or liquiritin to form nanoparticles, respectively. And the FT-IR and HRMS results indicated the possible binding of the ammonium group of kukoamine B with the phenolic hydroxyl group of mulberroside A or liquiritin, respectively. The established UPLC-MS/MS method was accurate and reliable and met the quantitative requirements. The pharmacokinetic behaviors of the N-XBSD and decoction were similar in rats. Most notably, compared to that of free drugs, the , AUC, AUC, and MRT values of index compounds were the higher in N-XBSD, with a slower plasma clearance rate in rats.
The major active compounds of XBSD were mainly distributed in N-XBSD, and N-XBSD was formed through self-assembly among active compounds. N-XBSD could obviously promote the bioavailability of active compounds, indicating natural nanoparticles of decoctions play an important role in therapeutic effects.
已发现天然纳米颗粒存在于中药汤剂中。然而,天然纳米颗粒是否会影响活性成分的口服生物利用度尚未阐明。本研究以泻白散汤剂(XBSD)为例,旨在分离、表征并阐明XBSD中纳米颗粒(N-XBSD)的形成机制,并进一步探讨N-XBSD是否能提高主要活性成分的生物利用度。
从XBSD中分离出N-XBSD,研究其表征、形成机制,并评估其提高活性成分生物利用度的能力。
成功分离出N-XBSD,其平均粒径为104.53 nm,多分散指数(PDI)为0.27,ζ电位为-5.14 mV。同时,所有8种活性成分在N-XBSD中含量最高。库可胺B可分别与桑色素苷A或甘草苷自组装形成纳米颗粒。傅里叶变换红外光谱(FT-IR)和高分辨质谱(HRMS)结果表明,库可胺B的铵基可能分别与桑色素苷A或甘草苷的酚羟基结合。所建立的超高效液相色谱-串联质谱(UPLC-MS/MS)方法准确可靠,满足定量要求。N-XBSD与汤剂在大鼠体内的药代动力学行为相似。最值得注意的是,与游离药物相比,N-XBSD中指标化合物的AUC、AUC、 和平均滞留时间(MRT)值更高,大鼠血浆清除率较慢。
XBSD的主要活性成分主要分布在N-XBSD中,N-XBSD是通过活性成分之间的自组装形成的。N-XBSD可显著提高活性成分的生物利用度,表明汤剂中的天然纳米颗粒在治疗效果中起重要作用。